Cancer charities have condemned a decision not to licence a drug being trialled in our region which extends the life of women suffering the advanced stages of breast cancer.
The National Institute for Clinical Excellence - or NICE - says the drug "Perjeeta" isn't cost effective.
Perjeeta is currently being tested on women through the Christie Hospital in Manchester - but it isn't routinely available on the NHS.
Cancer charities and women taking the drug want NICE to reconsider .
Ashley Derricott reports.
More top news
A man has been convicted of killing his girlfriend who was found stabbed to death at their home in Rochdale.
Cloudy & damp. Turning warm and humid into Tuesday. Kerrie has the latest.....
Rare miniature wallabies are set to go on show at Chester Zoo.